Broadwood Partners, L.P., 10% Owner at Oncocyte Corp (OCX), bought 12,007,504 shares at $1.33 ($16.0M) on 2022-04-14, disclosed to the SEC on 2022-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.33 | 6,003,752 | $8.0M | 50.0% |
| 2 | $1.33 | 6,003,752 | $8.0M | 50.0% |
| Total | $1.33 avg | 12,007,504 | $16.0M | 100% |
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |